Fund Holdings — Aquilo Capital Management, LLC

Total Portfolio Value:
$133.42M
Total Bought:
$14.70M
Total Sold:
$23.86M
Net Transaction:
-$9.16M
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Arrowhead Pharmaceuticals, Inc.(ARWR)908,474908,4740$27.80M$25.98M19.47%-$1.82M
REGENXBIO Inc.(RGNX)802,424906,248+103,824$14.40M$19.09M14.31%+$4.69M
Blueprint Medicines Corp254,827182,151-72,676$23.51M$17.28M12.95%-$6.23M
Arvinas, Inc.(ARVN)489,153405,766-83,387$20.13M$16.75M12.55%-$3.38M
Kymera Therapeutics, Inc.(KYMR)881,337388,743-492,594$22.44M$15.63M11.71%-$6.81M
Silence Therapeutics plcADS(SLN)1,043,284574,214-469,070$18.12M$12.40M9.30%-$5.72M
Merus N V355,109255,109-100,000$9.77M$11.49M8.61%+$1.72M
Sutro Biopharma, Inc.(STRO)420,6491,165,466+744,817$1.80M$6.58M4.94%+$4.78M
Precision BioSciences, Inc.(DTIL)0385,440+385,440$0$5.23M3.92%+$5.23M
Repare Therapeutics Inc633,271633,2710$4.62M$2.98M2.24%-$1.64M
Page 1 of 1
Aquilo Capital Management, LLC — 13F Holdings — Q1 2024 | TickerTrail